Abstract
The objective of the study was to evaluate the effectiveness of antibiotic-based polymethylmethacrylate (ab-PMMA) beads in achieving wound sterilization and graft preservation in patients with vascular graft infections. We reviewed 31 patients treated for 37 graft infections over the past 5 years using ab-PMMA beads in a single institution. All patients were started on broad-spectrum antibiotics and later switched to targeted therapy based on intraoperative cultures for at least 6 weeks. All patients underwent multiple planned wound explorations, debridements and washouts. Cultures were obtained each time. Decision to do formal closure depended on culture results and wound appearance. All wounds were closed with a muscle flap. The endpoints included wound sterilization, limb salvage, recurrence of infection, and graft preservation. A total of 19 different organisms were cultured, and 48.6% of cases were polymicrobial, thereby accounting for a total of 60 isolates. The majority (n = 27) received a mix of tobramycin/vancomycin PMMA beads; vancomycin beads (n = 5); tobramycin beads (n = 1); and gentamicin/vancomycin beads (n = 4). Wound sterilization based on cultures was achieved in 32 of 34 wounds (94.1%). Of the cases, 5 underwent early graft removal, 3 with immediate reconstruction, and 1 case underwent a major amputation (2.7 %). Graft preservation was attempted in 32 cases (86.5%). No death occurred within 30 days. Limb salvage was achieved in 28 of the 32 preserved graft cases (87.5%) at a mean follow-up of 26 months (6 to 51 months). The long-term limb salvage rate for the cohort was 86.5%. Of the patients, 4 presented with recurrent graft infection and occlusion, causing acute limb ischemia and resulting in major amputation. The reinfection rate was 12.5% in the graft-preservation group and 11.4% in both the graft-preserved and the in situ replacement groups. Sterilization of graft infection can be achieved with ab-PMMA beads followed by closure with muscle flap, resulting in an acceptable limb-salvage rate despite virulent or polymicrobial graft infection.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.